What are the odds of a child being diagnosed with cancer before age 20?
Evidence quality 4.75/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 4/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 5/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, subgroup
1 in 285
0.4% lifetime chance
Most people overestimate this.
range 1 in 333 to 1 in 250
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
Parents consistently rank childhood cancer among their greatest fears, and the perceived probability sits well above the actual rate. The vividness and emotional weight of childhood cancer diagnoses in media coverage — charity drives, viral fundraising stories, celebrity disclosures — create an availability cascade that inflates intuitive estimates dramatically. When researchers ask parents to estimate the likelihood that their child will develop cancer before adulthood, the guesses routinely fall between 5% and 20%, far above the actual cumulative incidence of roughly 1 in 285. The gap is amplified by the severity of the outcome: even a very small probability feels large when the outcome is cancer in a child.
Rough estimate: Most parents would guess somewhere between 1 in 20 and 1 in 5 — roughly 14 to 57 times the actual rate
Source: editorial intuition, not polled
Actual
roughly 216 children diagnosed with cancer per 1,000,000 children per year (US, ages 0–19)
US children aged 0–19
Show derivation
NCI SEER data (2023 Cancer Statistics Review, Childhood Cancer Statistics table) reports approximately 15,780 new cancer cases per year among US children aged 0–19 (average 2016–2020). The US Census Bureau estimated approximately 73 million children under age 20 in that period. Annual incidence rate: 15,780 / 73,000,000 ≈ 216 per million (21.6 per 100,000) per year. Cumulative childhood probability (20 independent annual-trial approximation): P = 1 − (1 − 0.000216)^20 ≈ 0.00430. However, NCI's own published summary statistic "approximately 1 in 285 children will be diagnosed with cancer before age 20" is the authoritative figure (0.003509) — it incorporates age-specific rate variation more precisely than the simple constant-rate approximation. This entry uses 0.00351 as the point estimate, consistent with the NCI published summary. Scope: subgroup_lifetime — probability that a given child receives a cancer diagnosis during their 0–19 childhood, not a US adult's remaining lifetime probability.
Caveats: This entry covers all cancer types (malignant neoplasms) diagnosed before age 20…
This entry covers all cancer types (malignant neoplasms) diagnosed before age 20 in the US. The headline figure "1 in 285" is NCI's published cumulative incidence summary for the childhood period and is the most authoritative single-number characterization of this risk. It does not include benign brain tumors, which are separately tracked and roughly double the total intracranial tumor burden. The 5-year survival rate has improved dramatically from roughly 58% in the mid-1970s to approximately 85% today, meaning that a childhood cancer diagnosis is no longer synonymous with a fatal prognosis for most types. Survival rates vary substantially by cancer type: acute lymphoblastic leukemia (the most common type) now has a 5-year survival exceeding 90%, while diffuse intrinsic pontine glioma (DIPG) remains near-uniformly fatal. The personal factor multipliers for Down syndrome and Li-Fraumeni syndrome apply to very specific genetically defined populations and should not be extrapolated to general familial cancer history without genetic counseling. Racial/ethnic disparities exist in childhood cancer incidence (higher rates in White children for ALL; higher rates of certain tumors in other groups) and in survival outcomes.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Infant pool submersion
What are the odds of a pool submersion injury serious enough to need emergency care for a child under 4?
Unsafe imported products
What are the odds of being harmed by an unsafe imported consumer product?
Counterfeit medicine
What are the odds of being harmed or killed by a counterfeit or substandard medicine?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
The National Cancer Institute’s SEER program estimates that approximately 15,780 children and adolescents aged 0–19 are diagnosed with cancer each year in the United States — roughly 1 in 285 children before their twentieth birthday. That cumulative incidence figure works out to about 216 per million children per year across the full 0–19 window. Leukemias account for 28% of cases, brain and other nervous system tumors 26%, and lymphomas 12%; the remainder spans a heterogeneous set of solid tumors including neuroblastoma, Wilms tumor, bone tumors, and soft-tissue sarcomas. Most parents, if asked to estimate the probability, give numbers far higher — often between 1 in 20 and 1 in 5 — placing their intuitive guess roughly 15 to 50 times above the actual rate. The gap is not surprising: childhood cancer diagnoses, because they are genuinely rare and emotionally freighted, receive media and fundraising attention wildly disproportionate to their statistical frequency, distorting the availability heuristic that underpins intuitive risk perception.
The survival landscape has been transformed over the past five decades in a way that is itself poorly understood by the public. The overall 5-year survival rate for childhood cancers has risen from roughly 58% in the mid-1970s to approximately 85% today, driven by advances in chemotherapy protocols, targeted agents, immunotherapy, and supportive care. Acute lymphoblastic leukemia — the most common childhood cancer — now carries a 5-year survival exceeding 90% in high-income countries. A childhood cancer diagnosis is a serious and demanding medical experience, but it is no longer, in most cases, a death sentence. This matters for risk perception: parents’ mental model of childhood cancer is often anchored in historical outcomes or in the highest-severity cases that generate the most coverage, compounding the probabilistic overestimate with a severity overestimate. The realistic scenario — roughly 85% of diagnosed children surviving beyond five years — is underweighted in intuitive assessments.
Risk is not uniform across the childhood period or across population subgroups. Incidence peaks in children aged 1–4 (driven by the ALL peak), declines in middle childhood, and rises again in adolescence with lymphomas, bone tumors, and germ cell tumors. Boys carry roughly a 20% higher overall incidence than girls, reflecting male predominance in leukemia and lymphoma. Genetic factors shift individual risk markedly in specific cases: children with Down syndrome face a 10–20-fold elevated risk of leukemia; Li-Fraumeni syndrome families carry substantially elevated risks of sarcomas, brain tumors, and other malignancies in childhood and adolescence. Childhood cancer survivors who received radiation therapy face an approximately 3-fold elevated risk of a second primary malignancy later in life — a risk that is real but borne by a subset of an already-small population. For the overwhelming majority of children without such predisposing conditions, the population-average figure of roughly 1 in 285 is the appropriate planning baseline.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program — Childhood Cancer Statistics — SEER Cancer Statistics Review 1975–2021
Childhood Cancer Statistics — SEER Cancer Statistics Review 1975–2021- Statistic
Approximately 15,780 children and adolescents aged 0–19 are diagnosed with cancer per year in the US (2016–2020 average); approximately 1 in 285 children will be diagnosed with cancer before age 20- Excerpt
“"In 2023, it is estimated that 9,910 children (ages 0-14) and approximately 5,280 adolescents (ages 15-19) in the United States will be diagnosed with cancer... About 1 in 285 children will be diagnosed with cancer before their 20th birthday." ”
- Source data from
- 2023-04-15
- Accessed
- 2026-05-10
- Calculation
- Primary rate and headline cumulative-incidence source. Annual case count 15,780 divided by approximate US children-under-20 population of ~73 million yields 216 per million per year → native numerator 216, denominator 1,000,000. The NCI-published summary "1 in 285" (= 0.003509) is used directly as the normalized lifetime_us_adult point estimate; it is more accurate than the constant-rate approximation (0.00430) because NCI applies age-specific incidence rates. The 0.00351 figure is preferred.
-
[2] CA: A Cancer Journal for Clinicians (American Cancer Society / ASCO) — Childhood and Adolescent Cancer Statistics, 2022
Childhood and Adolescent Cancer Statistics, 2022- Statistic
15,590 children (0–14) and 5,461 adolescents (15–19) diagnosed annually in the US; 5-year survival 84–85% overall; leukemia 28%, brain tumors 26%, lymphoma 12% of cases- Excerpt
“"An estimated 15,590 children (ages 0–14 years) and 5,461 adolescents (ages 15–19 years) will be diagnosed with cancer in the United States in 2022... The 5-year relative survival rate for all childhood cancers combined is approximately 84–85%... Leukemias represent approximately 28% of all childhood cancers, brain and other nervous system tumors about 26%, and lymphomas about 12%." ”
- Source data from
- 2022-01-13
- Accessed
- 2026-05-10 · archived copy
- Calculation
- Corroborating peer-reviewed source confirming annual incidence figures consistent with NCI SEER data: ~15,590 (ages 0–14) + ~5,461 (ages 15–19) = ~21,051 total, consistent with NCI's 2016–2020 estimate of ~15,780 for ages 0–19 (noting year-to-year variation and the different base period). Provides the type distribution (leukemia, brain, lymphoma) and overall 5-year survival rate (84–85%), which is essential context for the prose. Does not independently derive a cumulative lifetime probability; that calculation relies on the NCI SEER summary figure.